Sunday Nov 24, 2024
Wednesday, 15 December 2021 00:00 - - {{hitsCtrl.values.hits}}
The GSK Sri Lanka leadership team (from left): Head of Sales Tyrone Fernando, Ethics and Compliance Officer Ravindi Ratnayake, Manager Distribution, Exports and Tender Anuradha Alawattha, Head of HR Nirupa Wijeratne, Head of Marketing Tony Amath, Head of Finance Manoj Jayawardena, Head of Medical Affairs Dr. Chatura Jayakody, Country Head Sunder Ramachandran, Head of Regulatory Hemamali Tibbotumunuwa, Head of Quality Tharindra Siriwardhane, and Head of Logistics Dhanushke Fonseka
The GSK Sri Lanka team
The entire team of GSK Pharmaceuticals Ltd. Sri Lanka came together for an annual conference at the Anantara Kalutara resort to celebrate the achievements of the current year and align on the 2022
Country Head Sunder Ramachandran motivating the team |
objectives. The team engaged with global leaders within the company and discussed their plan to be ambitious for patients in Sri Lanka while doing business the right way.
The annual conference was designed on the theme of cricket with the intent to embed the champion’s spirit in every GSK colleague.
GSK Sri Lanka Country Head Sunder Ramachandran mentioned, “This is the first time that the team was meeting in person after nearly three years. The meeting acted as a catalyst in igniting our ambition to serve the patients in Sri Lanka by being a strong partner for health care professionals, distributors and our retail chemists.” The team also engaged with the top distributors in the country. Leading medical practitioners joined the conference to provide their perspective on the evolving healthcare landscape in Sri Lanka and how global companies like GSK can continue to provide best in class solutions. Peter D ‘Almeida, of Koombiyo fame and Colombo’s television and theatre scene, gave a keynote on how Sri Lankans can become world beaters and what it takes to win on the global stage.
GSK is a leading multinational pharmaceutical company with a local country office and a history of over 40 years of serving patients and consumers in Sri Lanka. It has leading market positions in the anti-infective and vaccines area with a growing respiratory and dermatology portfolio.